First Time Loading...

Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 14.36 USD 2.21% Market Closed
Updated: May 10, 2024

Entrada Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entrada Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Entrada Therapeutics Inc
NASDAQ:TRDA
EPS (Diluted)
$0
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$13
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$33
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Entrada Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-0.2 USD

Based on the financial report for Dec 31, 2023, Entrada Therapeutics Inc's EPS (Diluted) amounts to -0.2 USD.

What is Entrada Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
39%

Over the last year, the EPS (Diluted) growth was 93%. The average annual EPS (Diluted) growth rates for Entrada Therapeutics Inc have been 39% over the past three years .